chr20-63689576-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001283009.2(RTEL1):c.1953C>T(p.Arg651Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00417 in 1,612,290 control chromosomes in the GnomAD database, including 255 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0053 ( 27 hom., cov: 33)
Exomes 𝑓: 0.0040 ( 228 hom. )
Consequence
RTEL1
NM_001283009.2 synonymous
NM_001283009.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0570
Publications
3 publications found
Genes affected
RTEL1 (HGNC:15888): (regulator of telomere elongation helicase 1) This gene encodes a DNA helicase which functions in the stability, protection and elongation of telomeres and interacts with proteins in the shelterin complex known to protect telomeres during DNA replication. Mutations in this gene have been associated with dyskeratosis congenita and Hoyerall-Hreidarsson syndrome. Read-through transcription of this gene into the neighboring downstream gene, which encodes tumor necrosis factor receptor superfamily, member 6b, generates a non-coding transcript. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2013]
RTEL1-TNFRSF6B (HGNC:44095): (RTEL1-TNFRSF6B readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring RTEL1 (regulator of telomere elongation helicase 1) and TNFRSF6B (tumor necrosis factor receptor superfamily, member 6b, decoy) genes on chromosome 20. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is unlikely to produce a protein product. [provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 20-63689576-C-T is Benign according to our data. Variant chr20-63689576-C-T is described in ClinVar as Benign. ClinVar VariationId is 473911.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.057 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0903 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RTEL1 | ENST00000360203.11 | c.1953C>T | p.Arg651Arg | synonymous_variant | Exon 23 of 35 | 5 | NM_001283009.2 | ENSP00000353332.5 | ||
| RTEL1 | ENST00000508582.7 | c.2025C>T | p.Arg675Arg | synonymous_variant | Exon 23 of 35 | 2 | ENSP00000424307.2 | |||
| RTEL1 | ENST00000370018.7 | c.1953C>T | p.Arg651Arg | synonymous_variant | Exon 23 of 35 | 1 | ENSP00000359035.3 | |||
| RTEL1-TNFRSF6B | ENST00000492259.6 | n.2037C>T | non_coding_transcript_exon_variant | Exon 21 of 35 | 5 | ENSP00000457428.1 |
Frequencies
GnomAD3 genomes AF: 0.00528 AC: 803AN: 152172Hom.: 27 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
803
AN:
152172
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0113 AC: 2804AN: 248288 AF XY: 0.00953 show subpopulations
GnomAD2 exomes
AF:
AC:
2804
AN:
248288
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00405 AC: 5913AN: 1460000Hom.: 228 Cov.: 32 AF XY: 0.00382 AC XY: 2777AN XY: 726268 show subpopulations
GnomAD4 exome
AF:
AC:
5913
AN:
1460000
Hom.:
Cov.:
32
AF XY:
AC XY:
2777
AN XY:
726268
show subpopulations
African (AFR)
AF:
AC:
28
AN:
33478
American (AMR)
AF:
AC:
971
AN:
44660
Ashkenazi Jewish (ASJ)
AF:
AC:
13
AN:
26088
East Asian (EAS)
AF:
AC:
3885
AN:
39690
South Asian (SAS)
AF:
AC:
153
AN:
86186
European-Finnish (FIN)
AF:
AC:
63
AN:
52070
Middle Eastern (MID)
AF:
AC:
18
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
388
AN:
1111726
Other (OTH)
AF:
AC:
394
AN:
60336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
320
640
960
1280
1600
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00530 AC: 807AN: 152290Hom.: 27 Cov.: 33 AF XY: 0.00571 AC XY: 425AN XY: 74448 show subpopulations
GnomAD4 genome
AF:
AC:
807
AN:
152290
Hom.:
Cov.:
33
AF XY:
AC XY:
425
AN XY:
74448
show subpopulations
African (AFR)
AF:
AC:
58
AN:
41564
American (AMR)
AF:
AC:
160
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
AC:
4
AN:
3472
East Asian (EAS)
AF:
AC:
503
AN:
5168
South Asian (SAS)
AF:
AC:
16
AN:
4828
European-Finnish (FIN)
AF:
AC:
11
AN:
10616
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
47
AN:
68018
Other (OTH)
AF:
AC:
8
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
34
69
103
138
172
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
120
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Jan 22, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 12, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Dyskeratosis congenita, autosomal recessive 5;C4225346:Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Dyskeratosis congenita Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.